The women with breast cancer can improve their rate of treatment with a glass of red wine. The constituent resveratrol that naturally occurs in red wine boosts the effect of drug used to fight the disease. The lab tests have shown that constituents can prevent cancer cells from developing resistance to drug, called rapamycin.
The ingredient resveratrol is powerful antioxidant generated by plants like grapes, peanuts, raspberries and cranberries to ward off bacterial and fungal infections. Its potentials have already been investigating by researchers in reducing the threat of heart disease, Alzheimer’s and even the process of ageing.
However, researchers have now identified that plant chemical that provided red wine its red color and can make cancer drug more effective. The earlier study has recommended that a glass of red wine daily can protect against breast cancer as resveratrol blocked the way oestrogen combined with DNA in the body of a woman.
The resveratrol has also been associated anti-ageing properties. The most recent study points out that a tumour repressing gene called PTEN is triggered by resveratrol. Rapamycin has been used in clinical trials as a cancer treatment. Unluckily, eventually, the cancer cells develop resistance to rapamycin, explained Prof Charis Eng, of Cleveland Clinic’s Lerner Research Institute in Ohio.
Their findings demonstrate resveratrol appears to mitigate rapamycin-induced drug resistance in breast cancers, at least in lab studies. It reveals preservative effects between two compounds on repressing breast cancer cell signaling and growth. Rapamycin, resveratrol, and combinations of these mediators all repressed cell growth, with higher doses proving more effective, added Prof Eng.
But in spite of the latent for tumour repression rapamycin has generated jagged reactions in restraining the growth of various breast cancer cell lines. In the most recent tests the effect of resveratrol and rapamycin, alone and in combination, on cell growth of three human breast cancer cell lines was reviewed.